7 results on '"Julian Smith-Voudouris"'
Search Results
2. Fibroblast Isolation from Mammary Gland Tissue and Syngeneic Murine Breast Cancer Models
- Author
-
Margarita Bartish, Julian Smith-Voudouris, and Sonia V. del Rincón
- Published
- 2023
3. Fibroblast Isolation from Mammary Gland Tissue and Syngeneic Murine Breast Cancer Models
- Author
-
Margarita, Bartish, Julian, Smith-Voudouris, and Sonia V, Del Rincón
- Abstract
Cancer-associated fibroblasts (CAFs) are vital within the tumor ecosystem, regulating tumor growth, dissemination, and response to therapy through crosstalk with tumor cells, infiltrating immune and vascular cells, as well as components of the extracellular matrix (ECM). CAFs have thus emerged as potential therapeutic targets to complement cancer cell-targeted therapies. To study CAF-tumor cell crosstalk ex vivo, robust isolation methods of primary CAFs are required. Here, we present protocols to isolate, expand, and culture two types of fibroblasts: (1) healthy murine mammary gland fibroblasts, a key source of the CAF population in breast tumor models and (2) CAFs derived from syngeneic murine breast tumors. Isolated mammary fibroblasts and CAFs are suitable for use in a variety of downstream cellular and molecular experiments. We expect these methods to be useful to scientists studying the properties of fibroblasts and CAFs and the interaction between CAFs and the various components of the tumor microenvironment (TME).
- Published
- 2022
4. Commentary on 'Comparison of minimally invasive and open TLIF outcomes with more than seven years of follow-up'
- Author
-
Julian Smith-Voudouris and Jonathan N Grauer
- Subjects
Orthopedics and Sports Medicine ,Surgery ,Neurology (clinical) - Published
- 2022
5. The MNK1/2–eIF4E axis supports immune suppression and metastasis in postpartum breast cancer
- Author
-
Réjean Lapointe, Yao Zhan, Elie Khoury, Yirui Gui, Liesbeth Lenaerts, Dany Plourde, Margarita Bartish, Jörg H. Fritz, Sai Sakktee Krisna, Shannon A. Hewgill, Charles C.T. Hindmarch, Fan Huang, Tiziana Cotechini, Sonia V. del Rincón, Samuel E. J. Preston, Jie Su, Daniela F. Quail, Frédéric Amant, Claudia U. Duerr, Christophe Goncalves, Wilson H. Miller, Barbara C. Mindt, Giuseppe Floris, William Yang, Julian Smith-Voudouris, Qianyu Guo, Mark Basik, Vivian Zihui Li, Hanne Lefrère, Pamela Thebault, Valeria Narykina, Audrey Emond, Aurélie Cleret-Buhot, Yuhong Wei, Obstetrics and Gynaecology, CCA - Cancer biology and immunology, and ARD - Amsterdam Reproduction and Development
- Subjects
Cancer Research ,Stromal cell ,medicine.medical_treatment ,Mammary gland ,Breast Neoplasms ,Metastasis ,Mice ,Breast cancer ,Immune system ,Animals ,Humans ,Medicine ,Neoplasm Metastasis ,Immunosuppression Therapy ,Tumor microenvironment ,business.industry ,Postpartum Period ,Immunotherapy ,medicine.disease ,Metastatic breast cancer ,Disease Models, Animal ,Eukaryotic Initiation Factor-4E ,medicine.anatomical_structure ,Oncology ,Cancer research ,Female ,business - Abstract
Breast cancer diagnosed within 10 years following childbirth is defined as postpartum breast cancer (PPBC) and is highly metastatic. Interactions between immune cells and other stromal cells within the involuting mammary gland are fundamental in facilitating an aggressive tumor phenotype. The MNK1/2–eIF4E axis promotes translation of prometastatic mRNAs in tumor cells, but its role in modulating the function of nontumor cells in the PPBC microenvironment has not been explored. Here, we used a combination of in vivo PPBC models and in vitro assays to study the effects of inactivation of the MNK1/2–eIF4E axis on the protumor function of select cells of the tumor microenvironment. PPBC mice deficient for phospho-eIF4E (eIF4ES209A) were protected against lung metastasis and exhibited differences in the tumor and lung immune microenvironment compared with wild-type mice. Moreover, the expression of fibroblast-derived IL33, an alarmin known to induce invasion, was repressed upon MNK1/2–eIF4E axis inhibition. Imaging mass cytometry on PPBC and non-PPBC patient samples indicated that human PPBC contains phospho-eIF4E high–expressing tumor cells and CD8+ T cells displaying markers of an activated dysfunctional phenotype. Finally, inhibition of MNK1/2 combined with anti–PD-1 therapy blocked lung metastasis of PPBC. These findings implicate the involvement of the MNK1/2–eIF4E axis during PPBC metastasis and suggest a promising immunomodulatory route to enhance the efficacy of immunotherapy by blocking phospho-eIF4E. Significance: This study investigates the MNK1/2–eIF4E signaling axis in tumor and stromal cells in metastatic breast cancer and reveals that MNK1/2 inhibition suppresses metastasis and sensitizes tumors to anti–PD-1 immunotherapy.
- Published
- 2021
6. A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgia
- Author
-
Shad B. Smith, Richard G. Boles, Vivek Verma, Marc Parisien, William Maixner, Gillian L. Drury, Andrea G. Nackley, Miranda A.L. van Tilburg, Anne-Julie Chabot-Doré, Denniz Zolnoun, William E. Whitehead, Samar Khoury, Luda Diatchenko, Inna E. Tchivileva, Gary D. Slade, and Julian Smith-Voudouris
- Subjects
Orofacial pain ,medicine.medical_specialty ,Mitochondrial DNA ,Fibromyalgia ,Single-nucleotide polymorphism ,Article ,03 medical and health sciences ,0302 clinical medicine ,030202 anesthesiology ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Irritable bowel syndrome ,business.industry ,Chronic pain ,medicine.disease ,Heteroplasmy ,Mitochondria ,Minor allele frequency ,Anesthesiology and Pain Medicine ,Endocrinology ,Neurology ,Female ,Neurology (clinical) ,Chronic Pain ,medicine.symptom ,Energy Metabolism ,business ,030217 neurology & neurosurgery - Abstract
Alterations in cellular energy metabolism have been implicated in chronic pain, suggesting a role for mitochondrial DNA. Previous studies reported associations of a limited number of mitochondrial DNA polymorphisms with specific pain conditions. In this study, we examined the full mitochondrial genomes of people with a variety of chronic pain conditions. A discovery cohort consisting of 609 participants either with or without a complex persistent pain conditions (CPPCs) was examined. Mitochondrial DNA was subjected to deep sequencing for identification of rare mutations, common variants, haplogroups, and heteroplasmy associated with 5 CPPCs: episodic migraine, irritable bowel syndrome, fibromyalgia, vulvar vestibulitis, or temporomandibular disorders. The strongest association found was the presence of the C allele at the single nucleotide polymorphism m.2352T>C (rs28358579) that significantly increased the risk for fibromyalgia (odds ratio [OR] = 4.6, P = 4.3 × 10). This relationship was even stronger in women (OR = 5.1, P = 2.8 × 10), and m.2352T>C was associated with all other CPPCs in a consistent risk-increasing fashion. This finding was replicated in another cohort (OR = 4.3, P = 2.6 × 10) of the Orofacial Pain: Prospective Evaluation and Risk Assessment study consisting of 1754 female participants. To gain insight into the cellular consequences of the associated genetic variability, we conducted an assay testing metabolic reprogramming in human cell lines with defined genotypes. The minor allele C was associated with decreased mitochondrial membrane potential under conditions where oxidative phosphorylation is required, indicating a role of oxidative phosphorylation in pathophysiology of chronic pain. Our results suggest that cellular energy metabolism, modulated by m.2352T>C, contributes to fibromyalgia and possibly other chronic pain conditions.
- Published
- 2020
7. Phosphorylation of eIF4E in the stroma drives the production and spatial organisation of collagen type I in the mammary gland
- Author
-
Samuel E.J. Preston, Margarita Bartish, Vincent R. Richard, Arash Aghigh, Christophe Gonçalves, Julian Smith-Voudouris, Fan Huang, Paméla Thébault, Aurélie Cleret-Buhot, Réjean Lapointe, François Légaré, Lynne-Marie Postovit, René P. Zahedi, Christoph H. Borchers, Wilson H. Miller Jr., and Sonia V. del Rincón
- Subjects
Proteomics ,Breast Neoplasms ,Collagen Type I ,Mice ,Eukaryotic Initiation Factor-4E ,Serine ,Tumor Microenvironment ,Animals ,Humans ,Female ,Collagen ,Phosphorylation ,Mammary Glands, Human ,Molecular Biology - Abstract
The extracellular matrix (ECM) plays critical roles in breast cancer development. Whether ECM composition is regulated by the phosphorylation of eIF4E on serine 209, an event required for tumorigenesis, has not been explored. Herein, we used proteomics and mouse modeling to investigate the impact of mutating serine 209 to alanine on eIF4E (i.e., S209A) on mammary gland (MG) ECM. The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD028953. We discovered that S209A knock-in mice, expressing a non-phosphorylatable form of eIF4E, have less collagen-I deposition in native and tumor-bearing MGs, leading to altered tumor cell invasion. Additionally, phospho-eIF4E deficiency impacts collagen topology; fibers at the tumor-stroma boundary in phospho-eIF4E-deficient mice run parallel to the tumor edge but radiate outwards in wild-type mice. Finally, a phospho-eIF4E-deficient tumor microenvironment resists anti-PD-1 therapy-induced collagen deposition, correlating with an increased anti-tumor response to immunotherapy. Clinically, we showed that collagen-I and phospho-eIF4E are positively correlated in human breast cancer samples, and that stromal phospho-eIF4E expression is influenced by tumor proximity. Together, our work defines the importance of phosphorylation of eIF4E on S209 as a regulator of MG collagen architecture in the tumor microenvironment, thereby positioning phospho-eIF4E as a therapeutic target to augment response to therapy.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.